Sort   by:  
 Page size 
UnknownSimultaneous cross-evaluation of heterogeneous E. coli datasets via mechanistic simulation.
Not available
S-EPMC7990026 | biostudies-literature
UnknownA dominant role for the methyl-CpG-binding protein Mbd2 in controlling Th2 induction by dendritic cells.
Not available
S-EPMC4413429 | biostudies-literature
UnknownRisk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.
Not available
S-EPMC9046095 | biostudies-literature
UnknownInterleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
Not available
S-EPMC7953461 | biostudies-literature
UnknownResidual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
Not available
S-EPMC12860639 | biostudies-literature
UnknownSuspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials.
Not available
S-EPMC3729659 | biostudies-literature
UnknownSafety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Not available
S-EPMC7723445 | biostudies-literature
UnknownA controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
Not available
S-EPMC3587293 | biostudies-literature
UnknownSingle-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Not available
S-EPMC7894131 | biostudies-literature
UnknownPrevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.
Not available
S-EPMC10005893 | biostudies-literature
Sort   by:  
 Page size